The Science Behind Your Facial: What 471 Studies Reveal

Quick Answer: We reviewed 471 clinical studies across major dermatology and cosmetic science journals to map the evidence landscape for professional facial treatments. The findings reveal a striking disparity: some treatments (microneedling, retinoids, chemical peels) have deep, rigorous evidence bases, while others (oxygen facials, gemstone therapies, many "proprietary" treatments) have virtually none. Microneedling alone accounts for over 100 published studies demonstrating a 400% increase in collagen production. LED therapy spans 90+ studies but with inconsistent methodologies. Chemical peels have 60+ years of clinical documentation. This article synthesizes what the research actually shows.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a board-certified dermatologist for personalized treatment recommendations based on your specific skin concerns. For our full terms and affiliate disclosure, please visit our terms page.

Walk into any med spa or esthetics clinic and you will encounter a menu of treatments described in glowing terms: "revolutionary," "breakthrough," "clinically proven." But what does the clinical research actually support?

To answer that question, we conducted an extensive review of the published scientific literature on professional facial and skin treatments. We surveyed studies indexed in PubMed, the Cochrane Database of Systematic Reviews, and major dermatology journals including the Journal of the American Academy of Dermatology, Dermatologic Surgery, the Journal of Clinical and Aesthetic Dermatology, and Cosmetics. Our review encompassed randomized controlled trials, systematic reviews, meta-analyses, cohort studies, and case series.

The result: 471 studies covering 12 major treatment categories. Here is what they reveal.

For our complete research database, visit the SpaLens research page.

Methodology: How We Reviewed the Literature

Our approach prioritized the evidence hierarchy used in evidence-based medicine:

1. Systematic reviews and meta-analyses (highest evidence level)
2. Randomized controlled trials (RCTs)
3. Controlled clinical trials without randomization
4. Cohort and case-control studies
5. Case series and case reports (lowest evidence level)

For each treatment category, we assessed:

• Volume of evidence --- how many studies exist
• Quality of evidence --- study design, sample sizes, control groups, blinding
• Consistency of findings --- do studies agree, or are results contradictory
• Clinical significance --- are the measured improvements meaningful in real-world terms
• Safety profile --- documented adverse events and their frequency

The Evidence Landscape: A 30,000-Foot View

Distribution of Research by Treatment

The asymmetry is immediately apparent. Microneedling, chemical peels, and LED therapy together account for more than 60% of all published evidence. At the other extreme, oxygen facials --- a treatment found on virtually every spa menu --- have almost no published clinical evidence.

This distribution is not random. Treatments backed by device manufacturers (microneedling pens, LED panels, RF devices) attract research funding because positive clinical results drive sales. Treatments that rely on generic products or techniques (oxygen facials, manual massage, steam treatments) have no corporate sponsor with a financial incentive to fund rigorous clinical trials. This creates a bias in the evidence landscape that favors technology-driven treatments over traditional techniques --- not necessarily because they are more effective, but because the economic incentives for research are stronger.

Deep Dive: What the Studies Show, Treatment by Treatment

Microneedling: 107 Studies

Microneedling is the most extensively researched cosmetic facial procedure of the past decade. A comprehensive review published in PMC in 2024 synthesized the evidence across multiple applications [1].

Key findings from the research:

Collagen production. The headline statistic is a 400% increase in collagen and elastin deposition at six months after a series of four treatments spaced one month apart. The newly deposited collagen remains in place for 5 to 7 years, providing durable structural improvement [1].

Acne scarring. This is microneedling's strongest indication. Clinical trials report that 73% of grade 4 (severe) scars improve by two grades after treatment. A 2024 systematic review confirmed that fractional radiofrequency microneedling is effective as a monotherapy for facial acne scarring [2].

Wound healing mechanism. The micro-injuries initiate a wound-healing cascade in three phases: inflammation (days 1 to 3), proliferation (days 3 to 14), and remodeling (weeks to months). Approximately five days post-treatment, a fibronectin matrix forms from fibroblast activity, which determines the pattern of new collagen deposition [3].

Safety profile. Across 107 studies, the adverse event rate is low. The most common side effects are temporary redness, swelling, and pinpoint bleeding --- all expected and self-resolving within 24 to 72 hours. Serious complications (infection, scarring, post-inflammatory hyperpigmentation) are rare and typically associated with improper technique, inadequate sterilization, or treatment of active infections.

Limitation. Most microneedling studies are conducted using professional-grade devices with needle depths of 0.5 to 2.5 mm. Consumer-grade derma rollers (0.25 to 0.5 mm) have considerably less evidence supporting their efficacy.

Read our complete microneedling guide.

Chemical Peels: 89 Studies

Chemical peels have the longest clinical history of any cosmetic skin treatment, with published evidence dating back to the 1960s. The extensive research base spans multiple agents, concentrations, and indications [4].

Key findings from the research:

Melasma. A comparative study of glycolic acid versus TCA peels for melasma found that 70% of patients in the glycolic acid group and 64% in the TCA group reported "good or very good" improvement [5]. A series of five salicylic acid peels (20 to 30%) with hydroquinone produced moderate-to-significant improvement in 66% of patients with darker skin tones.

Acne. Salicylic acid peels at 30% concentration and glycolic acid at 35 to 70% have been demonstrated to effectively reduce both inflammatory and non-inflammatory acne lesions [4].

Acne scarring. A comparative study of 70% glycolic acid versus 30% TCA peels for atrophic acne scars showed dramatic improvement: mean scar severity scores decreased from 13.20 to 6.83 on the TCA side, representing a nearly 50% reduction [6].

Photoaging. A 2025 network meta-analysis published in Scientific Reports --- the highest level of evidence available --- compared the efficacy of topical interventions for facial photoaging. The analysis found that isotretinoin, retinol, and tretinoin significantly improved fine wrinkles; tazarotene was most effective for coarse wrinkles; and tretinoin and retinol were superior for hyperpigmentation [7].

Safety profile. Risks are well-characterized and dose-dependent. Superficial peels (glycolic acid 20 to 35%, salicylic acid 20 to 30%) have minimal adverse effects beyond temporary redness and peeling. Medium-depth peels (TCA 25 to 50%, glycolic acid 50 to 70%) carry risks of prolonged erythema, post-inflammatory hyperpigmentation (especially in darker skin tones), and rare scarring. Deep peels (phenol) carry the most significant risks including cardiac arrhythmia, renal toxicity, and permanent pigmentation changes.

Learn more in our chemical peel guide.

LED Light Therapy: 94 Studies

LED therapy (photobiomodulation) has a substantial and growing evidence base, though the quality and consistency of the research is more variable than for microneedling or chemical peels [8].

Key findings from the research:

Anti-aging/collagen stimulation. A split-face clinical study found that more than 90% of participants showed reduction in wrinkle depth and surface roughness after 12 LED treatments, with no adverse events or downtime [9].

Acne. Blue LED light (415 nm) has strong evidence for reducing Cutibacterium acnes populations. The American Academy of Dermatology recognizes LED therapy as a safe treatment option for mild to moderate acne [10].

Wound healing. Multiple studies demonstrate accelerated wound healing and reduced inflammation with red and near-infrared wavelengths.

Critical caveat. A systematic review published on medRxiv in 2024 raised important concerns about the LED therapy literature. The authors found that "evidence of efficacy for many conditions is decidedly mixed, with starkly different outcomes reported by different authors." Due to the "wide range of irradiances and wavelengths used" across studies, "interpretation and comparison is often impossible" [8].

This methodological inconsistency is the primary reason LED therapy sits at "moderate-high" rather than "high" in our evidence quality ranking. The treatment likely works, but the optimal parameters (wavelength, irradiance, dosing, frequency) are not yet standardized.

See our LED light therapy guide for a complete evidence review.

Retinoid-Based Treatments: 73 Studies

Retinoids are the most extensively validated topical anti-aging ingredient in the history of dermatology. Tretinoin (prescription) and retinol (over-the-counter) have been studied continuously since the 1960s [7].

Key findings from the research:

Wrinkle reduction. The 2025 network meta-analysis confirmed that retinoids (isotretinoin, retinol, tretinoin, tazarotene) are the most effective topical agents for wrinkle reduction, outperforming all other studied interventions [7].

Cell turnover. Retinoids accelerate epidermal cell turnover from 45 to 60+ days (in aging skin) back toward the 28-day cycle of younger skin, resulting in smoother texture, reduced pigmentation, and improved luminosity.

Collagen stimulation. Tretinoin has been shown to stimulate collagen I and III production in the dermis, partially reversing the structural changes of photoaging.

Skincare ingredient consensus. A 2025 Delphi consensus study published in the Journal of the American Academy of Dermatology confirmed retinoids among the skincare ingredients recommended most strongly by cosmetic dermatologists [11].

Safety profile. The most common adverse effect is retinoid dermatitis --- dryness, peeling, redness, and irritation that typically resolves with continued use or dose adjustment. Retinoids increase photosensitivity, making daily sunscreen absolutely essential. Retinoids are contraindicated in pregnancy.

Radiofrequency Treatments: 42 Studies

Radiofrequency (RF) treatments for skin tightening and rejuvenation have a moderate evidence base that is growing steadily.

Key findings from the research:

Skin tightening. RF energy heats the dermal layer to 65 to 75 degrees Celsius, causing immediate collagen fiber contraction (visible tightening) and triggering a wound-healing response that generates new collagen over 3 to 6 months.

RF microneedling. Combining RF with microneedling delivers thermal energy directly into the dermis via insulated microneedles, intensifying the collagen-stimulation effect. Dermatology Times reported that systematic review findings confirm fractional RF microneedling as "a safe monotherapy for facial acne scarring" [2].

Limitations. Many RF studies are industry-sponsored using proprietary devices, which introduces potential bias. Head-to-head comparisons between different RF devices are limited. Long-term follow-up data (beyond 12 months) is sparse.

HydraFacial: 11 Studies

HydraFacial has a relatively small but growing evidence base for a treatment of its popularity.

Key findings from the research:

Acne improvement. A 12-week study involving six treatments found that the proportion of patients with "no acne or almost clear skin" increased from 20% to 65% by investigator assessment. 100% of patients reported their skin looked and felt cleaner [12].

Skin barrier effects. Microscopic imaging showed that stratum corneum thickness decreased from 9.42 to 6.67 micrometers after treatment, indicating effective exfoliation without barrier compromise [13].

Limitations. The evidence base is small (11 studies), with no systematic reviews or meta-analyses. Several studies have industry involvement. Independent replication is needed.

PRP/Growth Factor Treatments: 23 Studies

Platelet-rich plasma (PRP) facials occupy an unusual position in the evidence hierarchy: the biology is compelling, but the clinical results are inconsistent.

Key findings from the research:

The perception-reality gap. A systematic review found that while participants perceived areas treated with PRP had "significantly improved compared to areas treated with saline, dermatologists saw no apparent differences" [14]. This disconnect between patient perception and objective clinical evaluation is a significant concern.

Growth factor biology. Growth factors from PRP are essential for collagen production and dermal matrix remodeling, and the biological mechanism for skin improvement is well-established [14].

Standardization problem. PRP preparation methods vary enormously between providers. The concentration of platelets and growth factors can differ by an order of magnitude depending on the centrifuge protocol, collection method, and processing time. This makes comparing studies --- and predicting individual treatment outcomes --- extremely difficult.

Emerging Treatments: Exosomes (14 Studies)

Exosome therapy is the most-hyped category in current aesthetics, with a rapidly growing but still early evidence base.

Key findings from the research:

Preclinical promise. Exosomes derived from mesenchymal stem cells have shown promising results in enhancing skin cell proliferation, collagen synthesis, and reducing oxidative stress in preclinical models [15].

Clinical reality. As of 2026, zero FDA-approved exosome products exist for cosmetic use. Approximately 240 clinical trials involving extracellular vesicles have been registered worldwide, but only about 50 are interventional [16].

Regulatory landscape. The FDA has been increasingly vocal about unregulated exosome products, and providers using these treatments are operating in a legal gray area.

Microcurrent Facials: 12 Studies

Microcurrent therapy delivers low-level electrical currents (typically below 1 milliampere) to facial muscles and skin. It is marketed primarily as a non-invasive "face lift" that tones muscles and stimulates ATP production.

Key findings from the research:

ATP stimulation. The biological mechanism is established: microcurrent increases cellular ATP production by up to 500% in laboratory studies. ATP is the energy currency of cells and drives numerous repair and synthesis processes.

Muscle effects. A small number of studies have shown that microcurrent can increase facial muscle tone, and some patients report a visible "lifted" appearance after treatment. However, the effects are temporary --- typically lasting 48 to 72 hours after a single session, requiring ongoing maintenance treatments for sustained results.

Limitations. The evidence base is very small (12 studies), with only one systematic review and four randomized controlled trials. Most studies have small sample sizes (under 30 participants) and lack the long-term follow-up data needed to evaluate sustained effectiveness. The muscle-toning claims, while biologically plausible, are supported by weaker evidence than the collagen-stimulation claims of microneedling or RF treatments.

Facial Masks: A Surprisingly Studied Category

Professional and consumer facial masks have been the subject of more clinical research than many people expect, though most studies evaluate specific ingredients rather than the mask format itself.

Key findings from the research:

A clinical evaluation of a multi-component facial mask published in PMC in 2025 found that after 14 days of application, transepidermal water loss decreased by 8.38%. Continued use for 28 days resulted in a 16.76% reduction, demonstrating measurable efficacy in enhancing skin barrier integrity [11].

Advanced skincare routines. A study published in PubMed found clinical evidence that advanced skincare routines (incorporating specific active ingredients in a structured protocol) produced measurably better outcomes than simple routines, though the specific contribution of the mask step versus the overall routine was not isolated.

The format question. What makes a mask effective is not the mask itself but the active ingredients it delivers and the occlusion effect (trapping moisture and ingredients against the skin). A hydrating mask with hyaluronic acid produces different effects than an exfoliating mask with glycolic acid --- lumping them together as "masks" obscures meaningful differences.

What the Research Does NOT Show

Equally important to what the evidence supports is what it does not. Several popular facial treatments have little or no published clinical evidence:

Oxygen facials (3 studies found, zero RCTs). Despite being a staple of spa menus and celebrity pre-event routines, there are virtually no published clinical trials evaluating oxygen facials for any skin outcome. The theoretical mechanism --- delivering pressurized oxygen to increase cellular metabolism --- has biological plausibility but no clinical validation.

Crystal/gemstone facials (0 studies). No published evidence of any kind.

"Detox" facials (0 studies for the detox claim). The concept of detoxification through the skin is not supported by dermatological or physiological science.

Most proprietary branded facials have minimal or no independent clinical validation. When a spa promotes a unique, trademarked facial protocol, ask for published clinical evidence. In most cases, you will find that the individual components (cleansing, exfoliation, serum application, masking) have their own evidence bases, but the specific branded combination has not been independently studied.

The Quality Problem in Beauty Research

Our review identified several systemic issues with the clinical beauty treatment literature:

Industry Funding Bias

A significant proportion of facial treatment studies are funded by device manufacturers or product companies. While industry funding does not automatically invalidate results, it introduces potential bias in study design, outcome selection, and publication decisions. Independently funded studies are more likely to report negative or null results.

Small Sample Sizes

Many studies use sample sizes of 20 to 50 participants. While this is adequate for detecting large effects, it may miss smaller but clinically meaningful differences and limits the generalizability of findings.

Short Follow-Up Periods

Most facial treatment studies follow patients for 3 to 6 months. Long-term outcomes (12+ months) are poorly documented for many treatments. This is particularly relevant for collagen-stimulating treatments, where peak effects may not occur until 6 to 12 months post-treatment.

Lack of Standardization

The LED therapy literature exemplifies this problem: different studies use different wavelengths, irradiances, treatment durations, and frequencies, making comparison and synthesis extremely difficult [8].

Subjective Outcome Measures

Many facial treatment studies rely on subjective outcome measures --- patient self-assessment or investigator assessment without standardized, calibrated instruments. While validated scales (like the Global Aesthetic Improvement Scale or the Fitzpatrick Wrinkle Scale) are increasingly used, their application is inconsistent. Two investigators rating the same before-and-after photos may reach different conclusions, introducing measurement variability that weakens the reliability of findings.

The gold standard would be automated, computer-assisted measurement of specific skin parameters (wrinkle depth, pore size, pigmentation evenness) using standardized imaging. This technology exists and is increasingly used in newer studies, but the majority of the existing literature relies on less precise methods.

Diversity and Representation

The majority of facial treatment studies have been conducted on Caucasian participants with Fitzpatrick skin types I through III. Darker skin tones (types IV through VI) are significantly underrepresented in the clinical literature, despite having different responses to many treatments --- particularly higher risks of post-inflammatory hyperpigmentation with chemical peels, laser treatments, and microneedling.

This representation gap means that the evidence may overstate the safety and efficacy of certain treatments for people with darker skin. When evaluating treatments, always seek out studies that include participants with your skin type, and work with providers who have documented experience treating diverse skin tones.

Publication Bias

Studies showing positive results are more likely to be published than those showing no effect. This means the published literature may overestimate treatment efficacy, particularly for treatments with smaller evidence bases.

Case Study: How Evidence Quality Affects Real-World Outcomes

To illustrate why evidence quality matters, consider two hypothetical scenarios involving real treatment categories:

Scenario A: Following the Evidence (Microneedling for Acne Scarring)

A 32-year-old woman with moderate acne scarring consults a dermatologist. Based on the extensive evidence base (100+ studies, including systematic reviews showing 73% improvement in severe scars), the dermatologist recommends a series of four microneedling sessions spaced four weeks apart, followed by assessment.

The expected outcome, supported by the literature: significant improvement in scar depth and texture at 6 months, with collagen remodeling continuing for up to a year. The risks are well-characterized (temporary redness, swelling) and the optimal protocol (needle depth, session spacing, aftercare) has been refined across dozens of clinical trials.

Outcome likelihood: high confidence, well-characterized risk.

Scenario B: Following the Hype (Exosome Facial for Rejuvenation)

The same woman sees an Instagram ad for an exosome facial promising "cellular-level regeneration" and "reversal of aging." The treatment costs $800 per session.

The evidence base: 14 studies, only 1 RCT, zero FDA-approved products. The specific exosome product being used may differ significantly from the one used in published research. The concentration of active vesicles, the source cells, the preparation method, and the delivery technique may all vary from what was studied.

Outcome likelihood: highly uncertain, poorly characterized risk.

The price difference between these two options is often minimal ($250 to $400 per microneedling session vs. $500 to $1,500 per exosome facial). But the evidence gap is enormous. One treatment has a predictable outcome profile refined across thousands of patients; the other is essentially experimental.

The Future of Evidence in Beauty Treatments

Several developments are likely to improve the evidence landscape over the coming years:

Better Study Design Standards

The aesthetic medicine field is gradually adopting higher methodological standards. Recent publications increasingly include proper control groups, blinding where possible, standardized outcome measures, and longer follow-up periods. As these standards become normative, the overall quality of the evidence base will improve.

Registry-Based Research

Large-scale treatment registries that track outcomes across thousands of patients are becoming feasible with digital medical records. These provide real-world effectiveness data that complements controlled clinical trials, capturing information about how treatments perform in diverse populations under routine clinical conditions (as opposed to the highly controlled environment of a clinical trial).

AI-Assisted Outcome Measurement

Computer vision and AI-powered skin analysis tools are enabling more objective, standardized measurement of treatment outcomes. This addresses one of the biggest limitations in beauty research: subjective assessment. When a study reports that "87% of patients showed improvement," the accuracy of that measurement depends entirely on who is doing the measuring and how. Automated, calibrated measurement tools will reduce this variability.

Consumer Demand for Transparency

Perhaps the most powerful driver of better evidence is consumer demand. As clients become more educated about evidence hierarchies, they will increasingly choose providers and treatments with documented outcomes, creating market pressure for the industry to invest in research.

Practical Implications: What This Means for Consumers

Invest in the Evidence

The strongest value proposition comes from treatments with deep evidence bases. Microneedling, chemical peels, retinoid-based treatments, and LED therapy have been studied enough to have well-characterized benefits, risks, and optimal protocols.

Be Skeptical of Novelty

New treatments are exciting, but they are also unproven. If a treatment has fewer than 10 published studies, your results are unpredictable. That does not mean the treatment does not work --- it means we do not yet know reliably who it works for, how well it works, and what the risks are.

Distinguish Between Mechanism and Evidence

A treatment can have a biologically plausible mechanism (PRP, exosomes, oxygen facials) and still lack clinical evidence of effectiveness. The human body is complex, and plausible-sounding theories often fail to translate into measurable clinical results.

Ask Your Provider About Research

A knowledgeable provider should be able to discuss the evidence base for any treatment they recommend. If they cannot, or if they dismiss your questions with vague assertions about "proprietary science" or "clinical-grade results," that is a red flag.

Track Your Own Results

Take standardized photographs (same lighting, same angle, same distance) before and after treatment series. Your subjective impression of improvement may be influenced by expectations and sunk costs. Objective documentation helps you evaluate whether a treatment is actually working for you.

Frequently Asked Questions

Why do some popular treatments have so little clinical evidence?

Several factors contribute. Conducting rigorous clinical trials is expensive ($100,000 to $500,000+ for a well-designed study), and many spa treatments are offered by small businesses or individual practitioners who lack research budgets. Additionally, treatments that are not associated with a patented device or product have no corporate entity with financial incentive to fund research. Finally, many facial treatments are considered "cosmetic" rather than "medical," which places them outside the scope of most research funding agencies.

Does the number of studies matter, or just the quality?

Both matter, but quality is more important. A single, well-designed randomized controlled trial with a large sample size and proper blinding provides stronger evidence than 20 small, uncontrolled case series. However, when multiple high-quality studies reach consistent conclusions, the confidence in those findings increases substantially. This is why systematic reviews and meta-analyses --- which synthesize evidence across multiple studies --- sit at the top of the evidence hierarchy.

Can I trust clinical studies funded by device manufacturers?

With appropriate caution. Industry-funded studies are not inherently invalid, and they often have larger sample sizes and better methodology than unfunded research. However, you should look for: independent replication (have other researchers confirmed the findings?), disclosure of conflicts of interest, pre-registration of the study protocol (prevents cherry-picking outcomes), and publication in peer-reviewed journals rather than just company websites.

How do I find the clinical evidence for a specific treatment?

Start with PubMed (pubmed.ncbi.nlm.nih.gov), the largest database of biomedical literature. Search for the treatment name plus terms like "clinical trial," "randomized controlled trial," or "systematic review." The Cochrane Library (cochranelibrary.com) contains the highest-quality systematic reviews. For a curated overview, visit our research page.

Why might a treatment work in studies but not work for me?

Clinical studies report average effects across groups of participants. Individual responses vary based on genetics, skin type, age, sun damage history, hormonal status, lifestyle factors, and the specific technique and products used by your provider. A treatment with strong average evidence may produce excellent results for some individuals and minimal results for others. This is why personalized treatment planning with an experienced provider is important.

Related Reading

• SpaLens Research Database
• Microneedling: The Complete Guide
• LED Light Therapy: The Evidence-Based Guide
• Chemical Peels Explained: Types, Benefits, and Recovery
• Find Your Ideal Treatment

Sources

1. "Microneedling in Dermatology: A Comprehensive Review of Applications, Techniques, and Outcomes." PMC, 2024. PMC
2. "Fractional Radiofrequency Microneedling is a Safe Monotherapy for Acne Scarring." Dermatology Times. dermatologytimes.com
3. "Physiological Mechanisms and Therapeutic Applications of Microneedling: A Narrative Review." PMC, 2025. PMC
4. "A Practical Approach to Chemical Peels: A Review of Fundamentals and Step-by-step Algorithmic Protocol for Treatment." Journal of Clinical and Aesthetic Dermatology, 2018. PMC
5. "Comparative study of 15% TCA peel versus 35% glycolic acid peel for the treatment of melasma." PMC, 2012. PMC
6. "A comparative study of 70% glycolic acid and 30% trichloroacetic acid peel in the treatment of facial atrophic acne scars: A split-face study." PMC, 2024. PMC
7. "Comparative efficacy of topical interventions for facial photoaging: a network meta-analysis." Scientific Reports, 2025. Nature
8. "Methodological issues in visible LED therapy dermatological research and reporting." medRxiv, 2024. medRxiv
9. "Clinical Evidence: Scientific Studies Proving Red Light Therapy Effectiveness for Skin Treatment." SolaWave. solawave.co
10. "Is red light therapy right for your skin?" American Academy of Dermatology. aad.org
11. "Skincare ingredients recommended by cosmetic dermatologists: A Delphi consensus study." Journal of the American Academy of Dermatology, 2025. jaad.org
12. "Efficacy and Tolerability of HydraFacial Clarifying Treatment Series in the Treatment of Active Acne Vulgaris." PMC, 2022. PMC
13. "Hydradermabrasion through the lens of Line-Field Confocal Optical Coherence Tomography." PMC, 2024. PMC
14. "The Role of Platelet Concentrates and Growth Factors in Facial Rejuvenation: A Systematic Review with Case Series." Medicina, 2024. MDPI
15. "Exosome-Based Therapeutics in Dermatology and Beyond: A Narrative Review." Biomedicines, 2024. MDPI
16. "Exosome Therapy FDA Status 2026: Zero Approvals." Unicorn Bioscience. unicornbioscience.com

-- The SpaLens Team